Tom Vaughan

Jun
16
Cost-effectiveness modeling suggests more targeted screening for esophageal adenocarcinoma

Cost-effectiveness modeling suggests more targeted screening for esophageal adenocarcinoma

Given that the incidence of esophageal adenocarcinoma in the U.S. varies dramatically by sex and race, it seems likely
2 min read
Jun
16
Significant updates to Barrett's screening, surveillance and treatment guidelines

Significant updates to Barrett's screening, surveillance and treatment guidelines

Important guideline updates include the recommendations for nonendoscopic screening methods, longer intervals for short-segment BE surveillance, and specific suggestions for
1 min read
Jun
13
Esophageal adenocarcinoma incidence increases in Netherlands

Esophageal adenocarcinoma incidence increases in Netherlands

The authors calculated temporal trends in esophageal adenocarcinoma from 1989-2016 in the Netherlands, finding substantial increases. They projected rates about
2 min read
May
11
Alcohol and esophageal squamous cell carcinoma in east Africa

Alcohol and esophageal squamous cell carcinoma in east Africa

A large multi-center study across three countries in east Africa confirms the significant role that alcohol intake plays in the
2 min read
May
10
Opportunities for esophageal cancer screening

Opportunities for esophageal cancer screening

Using the VA Central Cancer Registry, the authors investigated opportunites to undergo screening for esophageal adenocarcinoma (EAC), finding more than
1 min read
May
08
Indicators of prognosis among patients with esophageal adecnocarcinoma

Indicators of prognosis among patients with esophageal adecnocarcinoma

Dr. Matt Buas and colleagues analyzed clinical and lifestyle factors among 371 persons with esophageal adenocarcinoma. A number of factors
2 min read
May
07
Best practice guidelines for reducing use of PPIs

Best practice guidelines for reducing use of PPIs

Proton pump inhibitors (PPIs) are commonly used to treat  reflux, a key risk factor for esophageal adenocarcinoma. However, they have
3 min read
May
06
Prioritising BE surveillance using Cytsponge biomarker panel and clinical and epidemiologic risk factors

Prioritising BE surveillance using Cytsponge biomarker panel and clinical and epidemiologic risk factors

In addition to serving as a minimally invasive screening tool to help identify persons with Barrett's (BE), dysplasia and early
3 min read
May
04
Non-invasive capsule sponge with AI cytology shows promise for screening high-risk areas of China

Non-invasive capsule sponge with AI cytology shows promise for screening high-risk areas of China

Results from a study from a high-risk area in China indicate that esopphageal cells captured non-invasively via a capsule sponge, when combined with a trained artificial intelligence (AI) system can substantially reduce the need for endoscopy with histopathology, with a sensitivity of 93.7%.
2 min read
May
03
Evolution of esosphageal adenocarcinoma and implications for screening and surveillance

Evolution of esosphageal adenocarcinoma and implications for screening and surveillance

This nice review updates the molecular/genomic changes leading to esophageal adenocarcinoma and makes the link to more effective screening and treatment approaches.
1 min read